Overview

Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
To evaluate the impact of spironolactone treatment on renal autoregulation in hypertensive type 1 diabetic patients.
Phase:
Phase 4
Details
Lead Sponsor:
Steno Diabetes Center
Steno Diabetes Center Copenhagen
Treatments:
Spironolactone